BioLineRx's BL-8040 to be Presented at Upcoming Scientific Conferences

TEL AVIV, Israel, May 19, 2016 /PRNewswire/ —

BioLineRx Ltd. (NASDAQ/TASE: BLRX) announced today that BL-8040, its lead platform for the treatment of multiple cancer and hematological indications, will be presented at two upcoming scientific conferences.

An abstract titled “Clinical…
Source: PRNewsWire-USA

BioLineRx's BL-8040 to be Presented at Upcoming Scientific Conferences